Vote Scores
Filings read through

Cerevel Therapeutics Holdings, Inc.: how funds voted at the meeting of 16 Feb 2024

Meeting
Season
year to 30 June 2024
Filers reporting
295
Ballot items
3

295 filers on Form N-PX reported votes at the Cerevel Therapeutics Holdings, Inc. meeting of 16 Feb 2024. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Cerevel Therapeutics Holdings, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    409 vote records from 287 filers. 212 of the 273 filers that marked the item voted against management. 14 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 40 fund families
    • For 6
    • Against 33
    • Abstain or withhold 1
    • Against management 34
  2. Item 2: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    161 vote records from 95 filers. 0 of the 95 filers that marked the item voted against management.

    • Positions of 32 fund families
    • For 32
  3. Item 3: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    210 vote records from 113 filers. 17 of the 113 filers that marked the item voted against management.

    • Positions of 36 fund families
    • For 30
    • Against 6
    • Against management 6

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Cerevel Therapeutics Holdings, Inc., meeting of 16 Feb 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family1. Say-on-pay
AllianceBernsteinAgainst, against management
American CenturyAgainst, against management
BlackRock and iSharesAgainst, against management
BNY MellonAgainst, against management
Brighthouse FundsAgainst, against management
Capital Group and American FundsAgainst, against management
Charles SchwabAgainst, against management
Columbia ThreadneedleAgainst, against management
DimensionalAgainst, against management
DWSAgainst, against management
EquitableAgainst, against management
FidelityAgainst, against management
Global XAgainst, against management
Goldman SachsAgainst, against management
Guggenheim and RydexAgainst, against management
Harbor FundsFor
InvescoAgainst, against management
J.P. MorganAgainst, against management
Jackson National fundsAgainst, against management
Janus HendersonAgainst, against management
John Hancock and ManulifeAgainst, against management
Lincoln FinancialFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against management
NationwideAgainst, against management
Neuberger BermanFor
Northern Trust and FlexSharesAgainst, against management
Nuveen and TIAAAgainst, against management
Pacific Life fundsAgainst, against management
PGIM and PrudentialFor
PIMCOAgainst, against management
PrincipalAgainst, against management
ProShares and ProFundsAgainst, against management
SEIAgainst, against management
State Street and SPDRFor
T. Rowe PriceAgainst, against management
TransamericaAgainst, against management
VanguardAgainst, against management
Victory CapitalAgainst, against management
VirtusFor
VoyaAbstain, against management

Questions

How many filers reported votes at the Cerevel Therapeutics Holdings, Inc. meeting?
295 Form N-PX filers reported votes at the meeting of 16 Feb 2024. On say-on-pay, 212 of 273 filers that marked the item voted against management (77.7%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Cerevel Therapeutics Holdings, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Cerevel Therapeutics Holdings, Inc. with a meeting date within three days of 16 Feb 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .